Cargando…

Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device

Alternating electric field therapy has been approved for glioblastoma (GBM). We have preclinical evidence for anticancer effects in GBM cell cultures and mouse xenografts with an oscillating magnetic field (OMF) generating device. Here we report OMF treatment of end-stage recurrent glioblastoma in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baskin, David S., Sharpe, Martyn A., Nguyen, Lisa, Helekar, Santosh A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341943/ https://www.ncbi.nlm.nih.gov/pubmed/34367992 http://dx.doi.org/10.3389/fonc.2021.708017

Ejemplares similares

Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells
por: Sharpe, Martyn A., et al.
Publicado: (2021)

Spinning magnetic field patterns that cause oncolysis by oxidative stress in glioma cells
por: Hambarde, Shashank, et al.
Publicado: (2023)

The Leloir Cycle in Glioblastoma: Galactose Scavenging and Metabolic Remodeling
por: Sharpe, Martyn A., et al.
Publicado: (2021)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
por: Raghavan, Sudhir, et al.
Publicado: (2020)

PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma
por: Sharpe, Martyn A., et al.
Publicado: (2018)

Bevacizumab combined with re-irradiation in recurrent glioblastoma
por: She, Lei, et al.
Publicado: (2022)

Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug
por: Sharpe, Martyn A., et al.
Publicado: (2015)

Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer
por: Xu, Xiaopan, et al.
Publicado: (2021)

Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3
por: Sharpe, Martyn A., et al.
Publicado: (2015)

Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
por: Gupta, Kshama, et al.
Publicado: (2018)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
por: Dihge, Looket, et al.
Publicado: (2023)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma
por: Wang, Jing, et al.
Publicado: (2021)

A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
por: de Aquino, Priscila F., et al.
Publicado: (2016)

The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients
por: Lupa, Jakob T., et al.
Publicado: (2020)

A feasibility study of the Nativis Voyager(®) device in patients with recurrent glioblastoma in Australia
por: Murphy, Michael, et al.
Publicado: (2019)

Hijacking Sexual Immuno-Privilege in GBM—An Immuno-Evasion Strategy
por: Sharpe, Martyn A., et al.
Publicado: (2021)

Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts
por: Sharpe, Martyn A., et al.
Publicado: (2023)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme
por: Long, Hao, et al.
Publicado: (2023)

End Stage and Chronic Kidney Disease: Associations with Renal Cancer
por: Russo, Paul
Publicado: (2012)

The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
por: Zheng, Lin, et al.
Publicado: (2021)

Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
por: She, Lei, et al.
Publicado: (2021)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
por: Durgin, Joseph S., et al.
Publicado: (2021)

Recurrent glioblastoma metastatic to the lumbar vertebra: A case report and literature review: Surgical oncology
por: Matsuhashi, Ako, et al.
Publicado: (2023)

Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy
por: Li, Taoran, et al.
Publicado: (2018)

Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA
por: Sharpe, Martyn A., et al.
Publicado: (2012)

B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal
por: Sharpe, Martyn A., et al.
Publicado: (2013)

Alterations in Sensitivity to Estrogen, Dihydrotestosterone, and Xenogens in B-Lymphocytes from Children with Autism Spectrum Disorder and Their Unaffected Twins/Siblings
por: Sharpe, Martyn A., et al.
Publicado: (2013)

Multimodal analysis of genome-wide methylation, copy number aberrations, and end motif signatures enhances detection of early-stage breast cancer
por: Pham, Thi Mong Quynh, et al.
Publicado: (2023)

Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
por: Takei, Jun, et al.
Publicado: (2022)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience
por: Hasan, Shaakir, et al.
Publicado: (2015)

Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases
por: Yang, Gang, et al.
Publicado: (2022)

Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma
por: Anil, Aliya, et al.
Publicado: (2023)

FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial
por: Plaha, Puneet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7kv3pv9o2865ehs0afbvq0cdge